"Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from the prior quarterly rate. For income investors evaluating this healthcare giant's dividend sustainability, the payment arrives amid a complex backdrop: strong operational execution in medical devices offset by product recalls and nutrition segment weakness. With shares down 9.8% year-to-date, the 2.14% yield looks increasingly attractive, but does the dividend quality justify the investment?"
"The company has increased its dividend for 13 consecutive years, with the annual payout growing from $1.04 in 2016 to $2.36 in 2025 - a 127% total increase representing a 9.2% compound annual growth rate over the decade. The most recent quarterly increase from $0.59 to $0.63 continues this pattern, though the growth rate has moderated from the double-digit pace seen earlier in the decade."
Abbott Laboratories increased its quarterly dividend to $0.63 per share on February 13, 2026, a 6.8% rise that yields 2.14% as shares sit down 9.8% year-to-date. The company has raised its dividend for 13 consecutive years, with annual payouts rising from $1.04 in 2016 to $2.36 in 2025, a 127% total increase. Management affirmed commitment to a growing dividend. Fiscal 2024 operating cash flow was $8.56 billion and free cash flow was $6.35 billion after $2.21 billion in capital expenditures. Dividends paid totaled $3.84 billion, a 60.4% free cash flow payout ratio, up from 42.4% in 2022.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]